Technology Networks spoke with Dr. Anne‑Li Lind to learn more about how proteomics is being applied in neurology research.

A protein best known for its role in Parkinson’s disease can accelerate Alzheimer’s-related brain changes by up to 20 times in patients who carry elevated levels of both pathologies, according to new ...

As of Friday, March 13, Replimune Group, Inc.’s REPL share price has dipped by 7.58%, which has investors questioning if this is right time to buy.

Growing evidence suggests that getting enough high-quality sleep may help protect against memory problems later in life, ...

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2025.

For families of children with Dravet syndrome who have exhausted conventional treatment options, new hope is emerging.A first‑ever gene‑regulation ...

Trilaciclib protects bone marrow before SCLC chemotherapy, sharply reducing neutropenia, anemia, and thrombocytopenia, improving fatigue and keeping treatment on schedule without weakening tumor kill.

Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with this rare, devastating genetic neurodevelopmental dis ...

Severe COVID-19 raises lung cancer risk by 24%, study of 76 million Americans finds In A Nutshell People hospitalized with severe COVID-19 had roughly a 24 percent higher risk of developing lung ...

NAEs are lipid-based endogenous signaling molecules that are produced by combining long-chain fatty acids with ethanolamine. Collectively, NAEs include both endocannabinoids and structurally related ...